BGB-A317-30813-101
Active, not recruiting
A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Study ID 
BGB-A317-30813-101
ClinicalTrials.gov ID
EudraCT Number
2023-503996-38
China Drug Trials ID
CTR20233404
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
No Study Documents